C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/223, 260/266
C07D 403/06 (2006.01) A61K 31/495 (2006.01) C07D 249/12 (2006.01)
Patent
CA 1237723
Abstract of the Disclosure 2-[3-[4-(3-Halophenyl)-1-piperazinyl]propyl]-5-(1-hydroxy- ethyl)-2,4-dihydro-4-phenoxyalkyl-3H-1,2,4-triazol-3-ones and closely related compounds are psychotropic agents having promise as antidepressants by virtue of their receptor site binding affinity profiles and animal pharm- acology. The specification discloses compounds of Formula I and the acid addition salts of these substances. Image (I) In the foregoing structural formula the symbol R designates hydrogen, lower (C1-C4) alkyl, lower acyl, phenyl-lower-alkyl (such as benzyl), and phenyl- lower-acyl (such as phenacyl); Y is halogen, preferably chloro, or trifluoro- methyl; Z is hydrogen or Image , with R1 being hydrogen, halogen, C1-4 alkoxy, or trifluoromethyl; and n is 2-4.
464230
Gammans Richard E.
Smith David W.
Yevich Joseph P.
Bristol-Myers Company
Gowling Lafleur Henderson Llp
LandOfFree
Antidepressant 1,2,4-triazolone compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antidepressant 1,2,4-triazolone compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antidepressant 1,2,4-triazolone compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1266174